National Infusion Center Association
In 2025, NICA’s advocacy work delivered meaningful wins for non-hospital infusion providers by elevating provider voices, shaping policy debates, and driving real-world results at the state […]
Scale Intake Without Burning Out Your Team: Designing a Data-Driven Capacity Model A common refrain in Infusion, and in all parts of healthcare is: “We’re overwhelmed. […]
There’s much at stake if you are directly or indirectly responsible for moving medications from the manufacturer to a patient. Bryan Johnson goes in depth about the DSCSA […]
CMS is asking infusion providers to submit comments about selected drugs as part of the Medicare Drug Price Negotiation Program. This includes the first negotiations for […]
Government price setting policies, such as Upper Payment Limits (UPLs) established by Prescription Drug Affordability Boards (PDABs), can have real-world consequences for infusion providers and the […]
In November, I had the opportunity to represent the National Infusion Center Association (NICA) at the Rheumatology Nurses Society (RNS) Conference in San Antonio, Texas. The […]
Highlights, participant insights, and what’s next after our inaugural pre-conference workshop in Miami Beach. The infusion industry is changing rapidly. As demand for biologics and specialty […]
How Verification, Validation, and Value reporting can turn GenAI pilots into sustainable operational improvements Every infusion operator I know is thinking about AI right now. There […]
Tucked away in the Centers for Medicare and Medicaid Services (CMS) CY 2026 Home Health and DMEPOS final rule, CMS finalized several updates to Medicare provider […]
